Schering CEO
This article was originally published in The Rose Sheet
Executive Summary
Newly-appointed CEO Fred Hassan to "stabilize" and "turnaround" pharmaceutical firm's business, according to April 20 release. Former CEO of Pharmacia was widely speculated to be Schering's first choice for the post once the Pfizer/Pharmacia merger closed. Exec will face a number of challenges including Securities & Exchange Commission fair disclosure inquiry, FDA/Department of Justice investigation into good manufacturing practices in Puerto Rico. Hassan succeeds Richard Kogan, who stepped down from post in November...